Group 1 - The year 2025 marks the conclusion of the deepening reform actions for state-owned enterprises, with multiple regions intensifying policies to support mergers and acquisitions of state-owned enterprises [1] - Nanjing Tourism Group is set to integrate with Nanjing Cultural Investment Holding Group and Nanjing Sports Industry Group to create a comprehensive development and operation platform for cultural tourism and sports in Nanjing [1] - The Nanjing municipal government has issued measures to promote high-quality development of mergers and acquisitions, focusing on optimizing equity structure and enhancing operational efficiency [1] Group 2 - Nanjing Tourism Group is advancing a capital injection plan into Nanjing Commercial Tourism Co., which includes acquiring 100% equity of Nanjing Huangpu Grand Hotel through a combination of share issuance and cash payment [2] - The strategic restructuring of Nanjing Commercial Tourism's controlling shareholder aligns with national directives for deepening state-owned enterprise reforms, aiming to enhance the integration of tourism, culture, and sports sectors [2] - The restructuring is expected to significantly influence Nanjing Commercial Tourism's future strategic positioning and business expansion, allowing for the exploration of synergies across industries [2] Group 3 - In addition to the cultural tourism sector, there have been frequent mergers and acquisitions in energy, high-end equipment, and electronic information sectors this year [3] - Inner Mongolia Electric Power Investment Co. announced plans to restructure assets by acquiring 100% equity of Baiyin Hua Coal Power Co. to optimize resource allocation in the region [3] - China Shipbuilding Industry Co. is merging with China Shipbuilding Heavy Industry Co., with the merger approved by the Shanghai Stock Exchange's review committee [3] Group 4 - In the electronic information sector, Guotou Zhonglu Juice Co. plans to acquire 100% equity of China Electronic Engineering Design Institute through share issuance, expanding its business scope beyond juice production [4] - The year 2025 is critical for the deepening reform of state-owned enterprises, emphasizing the need for clear restructuring objectives and effective coordination mechanisms [4]

7月7日晚间，中核科技公告称，公司决定终止发行股份购买西安中核核仪器股份有限公司（以下简称中 核西仪）98.87%股份并募集配套资金的交易事项。 公告显示，中核科技筹划本次交易预计构成重大资产重组与关联交易，并且符合其所处行业通过并购重 组方式强化竞争力的发展趋势。 同时，上述交易是中国核工业集团有限公司（以下简称中核集团）将优质资产注入其控股上市公司的重 要举措。据悉，中核科技与中核西仪均由中核集团控制。 官网显示，中核集团是中央直接管理的特大型国有重要骨干企业，也是国家核科技工业的主体，资产规 模约为1.4万亿元。 市场环境与中核西仪有变 中核科技公告称，公司决定终止本次交易事项，主要是当前市场环境及中核西仪的实际情况，相比于本 次交易的筹划初期发生了一定的变化。 交易预案显示，截至2024年9月30日，中核科技的总资产为26.63亿元，净资产为14.91亿元。 2022年、2023年及2024年前三季度，中核科技的营业收入分别为11.49亿元、13.24亿元、6.63亿元，净 利润分别为1.77亿元、1.64亿元、8159.76万元。 | | | | 单位:万元 | | --- | --- | --- ...

Market Performance - On July 7, 2025, the Shanghai Composite Index rose by 0.02%, while the Shenzhen Component Index fell by 0.70% and the ChiNext Index decreased by 1.21%[3] - The total market turnover was 1,208.497 billion yuan, a decrease of 219.868 billion yuan compared to the previous trading day[3] - Out of 3,286 stocks, 2,010 declined while 1,276 advanced[3] Sector Performance - The top-performing sectors included Comprehensive Finance (up 2.21%), Real Estate (up 1.70%), and Electric Power & Utilities (up 1.50%) while the laggards were Pharmaceuticals (down 0.94%), Communications (down 0.80%), and Home Appliances (down 0.73%)[3][21] - The market style ranking was Stable > Financial > Cyclical > Neutral > Growth > Consumer[21] Capital Flow - On July 7, 2025, the net outflow of main funds was 18.268 billion yuan, with large orders seeing a net outflow of 11.283 billion yuan and small orders experiencing a net inflow of 19.967 billion yuan[4][26] - Southbound capital saw a net inflow of 12.067 billion HKD, with the Shanghai-Hong Kong Stock Connect contributing 5.791 billion HKD and the Shenzhen-Hong Kong Stock Connect contributing 6.276 billion HKD[5][28] ETF Trading - Major ETFs such as the Huaxia SSE 50 ETF and the Huatai-PB CSI 300 ETF saw significant decreases in trading volume, with changes of -7.82 billion yuan and -26.26 billion yuan respectively[4][31] - The total trading volume for ETFs on July 7 was 12.08497 billion yuan, reflecting a decrease from the previous trading day[31] Global Market Overview - On July 7, 2025, major Asia-Pacific indices showed mixed results, with the Hang Seng Index down 0.12% and the Nikkei 225 down 0.56%[5][34] - European indices also experienced declines, with the DAX down 0.61% and the CAC40 down 0.75% on July 4, 2025[5][34]

【 导读 】中核科技终止 筹划重大资产重组，系 市场环境及标的公司 有变 中国基金报记者 闻言 7月7日晚间，中核科技公告称，公司决定终止发行股份购买西安中核核仪器股份有限公司 （以下简称中核西仪）98.87%股份并募集配套资金的交易事项。 公告显示，中核科技筹划本次交易预计构成重大资产重组与关联交易，并且符合其所处行业 通过并购重组方式强化竞争力的发展趋势。 同时，上述交易是中国核工业集团有限公司（以下简称中核集团）将优质资产注入其控股上 市公司的重要举措。据悉，中核科技与中核西仪均由中核集团控制。 官网显示，中核集团是中央直接管理的特大型国有重要骨干企业，也是国家核科技工业的主 体，资产规模约为1.4万亿元。 市场环境与中核西仪有变 中核科技公告称，公司决定终止本次交易事项，主要是当前市场环境及中核西仪的实际情 况，相比 于 本次交易 的 筹划初期发生了 一定的变化。 交易预案显示，截至2024年9月30日，中核科技的总资产为26.63亿元，净资产为14.91亿 元。 2022年、2023年及2024年前三季度，中核科技的营业收入分别为11.49亿元、13.24亿元、 6.63亿元，净利润分别为1.77亿 ...

Mergers and Acquisitions - Hangcha Group's subsidiary plans to increase capital and acquire approximately 99% of Guozhi Robotics [1] - Changhong High-Tech is planning to purchase 100% equity of Guangxi Changke through share issuance and cash payment, which is expected to constitute a major asset reorganization [2] Shareholding Changes - Newray's senior management plans to reduce their holdings by up to 0.3% of the company's shares due to personal financial needs [3] - Zhuoyi Information's employee shareholding platform intends to reduce its holdings by up to 1.88% of the company's shares due to employees' financial needs [4] - Baotong Technology's major shareholders plan to collectively reduce their holdings by up to 2.36% of the company's shares for personal financial reasons [5] Performance Disclosure - Huayou Cobalt expects a year-on-year increase of 56% to 68% in net profit attributable to shareholders for the first half of 2025, driven by integrated operations and rising cobalt prices [6] - Skyworth Digital anticipates a year-on-year decline of 76% to 65% in net profit attributable to shareholders for the first half of 2025 due to a significant drop in sales prices of smart terminal products [7] - Shandong Molong expects a year-on-year decline of 92% to 94% in net profit attributable to shareholders for the first half of 2025, primarily due to the previous year's asset sales [8][9] Investment Matters - Jinhe Biological's wholly-owned subsidiary plans to invest 158 million yuan in a wastewater treatment expansion project to enhance future profitability [10] Risk Matters - Risconda's chairman and a director have been subjected to criminal coercive measures due to allegations of information disclosure violations [11]

比如，百亿级乃至千亿级大规模重大资产重组频现。前述中国船舶吸收合并中国重工即为典型案例，合 并后总资产将超过4000亿元。 再比如，随着监管一再强调鼓励加快上市公司向新质生产力转型步伐，在新增并购重组计划的上市公司 中，涉及半导体，以及计算机、通信和其他电子设备制造业领域的企业数量颇多。典型如华大九天定增 收购芯和半导体100%股权、富乐德定增收购富乐华100%股权、国科微定增收购中芯宁波94.366%股权 等。 另一个值得关注的信号是，在6月18日发布的科创板"1+6"新政中，监管支持上市公司聚焦做优做强主 业，吸收合并上市不满3年的科创板上市公司。在受访人士看来，这或将加速新上市企业的并购重组脚 步。 日前，中国船舶吸收合并中国重工100%股权获上交所审核通过。这是两大超千亿级旗舰造船上市公司 的合并，也是A股有史以来规模最大的上市公司吸收合并。 此次重组完成后，存续公司中国船舶将成为全球最大造船上市公司，资产规模、营业收入规模、手持订 单数均领跑全球。 并购重组，已然成为监管重点鼓励方向。从近期上市公司公告来看，无论是央企国企还是民营企业，并 购重组热情均颇为高涨。 日前，中国船舶吸收合并中国重工100 ...

Core Viewpoint - Jinbo Biological is not merely a cosmetic enterprise but a pioneer in the field of human-derived collagen, with significant technological advancements and market potential in the medical sector [1][12]. Group 1: Company Overview - Jinbo Biological (832982.BJ) announced a deep collaboration with Zhong Shanshan's Yangshengtang, involving a total investment of up to 34 billion yuan, which includes a 20 billion yuan capital increase and a 14.03 billion yuan share transfer [2][3]. - The company holds a 100% market share in the category of three types of medical devices related to collagen [2]. - The founder, Yang Xia, has transformed Jinbo Biological into a leader in the recombinant human collagen market, overcoming significant technical challenges [3][11]. Group 2: Technological Advancements - The company successfully developed the first recombinant type III collagen product in 2014, after years of research and overcoming various technical hurdles [5][6]. - In 2018, Jinbo Biological achieved a breakthrough by synthesizing a unique A-type recombinant type III human collagen with a specific triple helix structure, marking a significant advancement in the field [7][8]. - The company received regulatory approval for its recombinant type III human-derived collagen freeze-dried fiber product in June 2021, establishing it as a leader in the new biological materials sector [8][9]. Group 3: Financial Performance - Jinbo Biological's revenue surged from 233 million yuan in 2021 to 780 million yuan in 2023, reflecting a compound annual growth rate of 82.8% [9][12]. - Net profit increased dramatically from 57.39 million yuan to 732 million yuan, with a cumulative growth exceeding 500% [9]. - The gross margin improved from 82.29% in 2021 to 92.02% in 2023, surpassing that of major competitors [9]. Group 4: Market Position and Future Outlook - The company is positioned to enter the international beauty supply chain, including partnerships with major brands like L'Oréal, enhancing its market reach [9][10]. - Jinbo Biological aims to expand its product line to cover various medical applications, including oral, orthopedic, and gynecological fields, focusing on human tissue repair solutions [11][12]. - The market for recombinant collagen in China is projected to reach 58.6 billion yuan by 2025 and exceed 200 billion yuan by 2030, indicating a significant growth opportunity despite increasing competition [12].

腾讯出手了。 近日，晨壹基金旗下上海晨峦企业管理合伙企业（有限合伙）发生工商变更，新增广西腾讯创业投资有限公司、无锡晨壹成长股权投资基金（有限合伙）、 厦门金圆展鸿二期股权投资合伙企业（有限合伙）、珠海众烨投资企业（有限合伙）等为合伙人。 晨壹基金的掌门人——刘晓丹曾是华泰联合证券的灵魂人物，操刀不少经典案例，被称为"并购女王"。2019年，刘晓丹成立晨壹基金管理（北京）有限公 司，完成私募股权、创业投资基金管理人备案登记，任晨壹基金的管理合伙人，聚焦并购领域。 腾讯出手 天眼查显示，上海晨峦企业管理合伙企业（有限合伙）成立于2022年2月，执行事务合伙人为晨壹红启（北京）咨询有限公司，经营范围含企业管理、企业管 理咨询、信息咨询服务。该合伙企业由晨壹红启（北京）咨询有限公司、北京晨壹并购基金（有限合伙）等共同出资成立。 今年7月，上海晨峦企业管理合伙企业（有限合伙）的合伙人名单新增加了广西腾讯创业投资有限公司、无锡晨壹成长股权投资基金（有限合伙）、厦门金圆 展鸿二期股权投资合伙企业（有限合伙）、珠海众烨投资企业（有限合伙）、深圳舟益管理咨询合伙企业（有限合伙）等，注册资金由4.61亿元增至11.61亿 元。 ...

证券代码：002480 证券简称：新筑股份 成都市新筑路桥机械股份有限公司 编号：2025-003 | | 特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | 动类别 | □现场参观 | | | □其他 （请文字说明其他活动内容） | | 活动参与人员 | 1、公司接待人员：张杨、简杰； | | | 2、来访对象：安格斯商业管理（成都市）集团有限公司。 | | 时间 | 2025 年 07 月 07 日（星期一）下午 15:00-16:00 | | 地点 | 新筑股份办公楼 324 会议室 | | 形式 | 现场交流 | | | 一、公司情况介绍 | | | 成都市新筑路桥机械股份有限公司（以下简称"公司"） | | | 副总经理、董事会秘书张杨从历史沿革、产业布局等方面介绍 | | | 公司基本情况，并介绍了公司本次重大资产重组预案基本情 | | | 况。 | | | 二、问答环节 | | | 问 1：请介绍本次重组方案。 | | | 答：公司已披露重组预案，本次公司拟向四川蜀道轨道交 | | | 通集团 ...

Group 1 - The stock of Chengdu Xian Dao (688222) has a comprehensive score of 52.52, indicating a strong performance [1] - The main cost analysis shows that the current main cost is 16.08 yuan, with a 5-day main cost of 16.43 yuan and a 20-day main cost of 15.60 yuan [1] - Over the past year, the stock has experienced 0 limit-up days and 1 limit-down day [1] Group 2 - The short-term resistance level is at 16.68 yuan, while the short-term support level is at 16.08 yuan [2] - The mid-term resistance level is 17.20 yuan, and the mid-term support level is 15.38 yuan [2] - As of July 7, 2025, there was a net outflow of 29.15 million yuan in main funds, accounting for -17% of the total transaction amount [2]